Introduction/Objective. A pressure ulcer is a localized injury to the skin and/or underlying tissue, usually over a bony prominence. It appears as a result of pressure or combination of pressure and shear. Pressure ulcers can be identified within a wide variety of patient subpopulations and a major role in their treatment plays epidemiological and etiological aspects. Methods. A retrospective study of data analysis included 72 patients with pressure ulcers that were hospitalized and surgically treated during a five-year period at the Clinic for Burns, Plastic and Reconstructive Surgery of the University Clinical Center of Serbia in Belgrade. Main data features used in the analysis were: gender, age, principal diseases, comorbidities and biochemical indicators of malnutrition. The patients' data was obtained from the existing patients’ records. Additionally, the study analyzed the method of treating pressure ulcers, types of reconstructive methods in surgical treatment, as well as the incidence rate of partial osteotomy. Results. A total of 72 patients with pressure ulcers were included into this study with 54.7 ± 16.1 mean age. Three times more patients injured in traffic accidents were male (75% vs. 25%), while the most of the patients with multiple sclerosis were female (85.7%). More than 95% of patients who had pressure ulcers of III or IV stage were treated surgically with a reconstructive method of transposition or rotation myocutaneous flap. The patient with pressure ulcer of stage IV was usually treated with partial osteotomy. Conclusion. A surgical reconstructive treatment with fasciocutaneous and myocutanaeous flaps represents a gold standard for treating patients with pressure ulcers. These procedures provide reconstruction with adequate flap coverage and obliteration of dead space with well-vascularized tissue but with necessity of further implementation of antidecubitus measures.
1 January 2022 in Srpski arhiv za celokupno lekarstvo
Introduction. Toxic epidermal necrolysis (TEN), also known as Lyell’s syndrome, is rare exfoliative disorder with high mortality rate. This entity was first described by Lyell in 1956, who termed the condition ‘toxic epidermal necrolysis', pointing out that drug sensitization was generally considered to be the mechanism leading to this syndrome. The drugs most frequently involved are nonsteroidal anti-inflammatory drugs (NSAID), chemotherapeutic agents, antibiotics, and anticonvulsants, although virus, bacterial, and fungal infections, as well as immunization, have been described. Case outline. We present a 72-year-old man with the following history. Five days before he was admitted patient have had high fiver and pain throat. He was treated with antibiotics and nonsteroidal anti-inflammatory drugs (NSAID) because had had bronchopneumonia and after that he developed itchy skin rash over all body following with sensation of slight sore throat with conjunctival hyperaemia and hard breathing and high fiver and because of this he was hospitalized in the local hospital. After worsening of symptomatology following with urticaria like plaques and then bullae with progress all over the body patient was moved to our Institution and positioned in intensive care unit, under suspicion of TEN. The aim of the paper presented here is to give a thorough summary of our literature review searching for the best therapy modalities for our patient with TEN. Conclusion. We decided to present this case because our patient had been affected with lesions of multiorgan system and with affecting 80% TBSA and SCROTEN score 4. With early diagnosed of TEN patient was successfully treated.
1 January 2026 in Srpski arhiv za celokupno lekarstvo
Introduction. Guyon’s canal syndrome (GCS) is a rare compressive neuropathy, accounting for less than 1% of upper extremity neuropathies. While traumatic, inflammatory, or idiopathic causes are more common, tumor-related lesions remain an uncommon etiology. The objective of this report is to present two cases of GCS caused by space-occupying tumorous formations and to emphasize the importance of early diagnosis and surgical intervention. Case outline. The first case involves a 60-year-old civil engineer diagnosed with a benign cystic lesion within Guyon’s canal. The second case describes a 55-year-old editor with a lipomatous mass in the same region. Both patients developed progressive hand muscle weakness and sensory impairment. Magnetic resonance imaging and ultrasound confirmed ulnar nerve compression, while electrophysiological studies revealed severe neurogenic damage. Surgical excision of the lesions resulted in marked symptom improvement, and both patients achieved complete functional recovery. Conclusion. These cases demonstrate that surgical decompression of Guyon’s canal in tumor-related compressions provides excellent outcomes. Timely diagnosis and an individualized therapeutic approach are crucial to prevent permanent nerve damage.
Background: Primary cutaneous apocrine carcinoma (PCAC), a subtype of sweat gland carcinoma, is an extremely rare malignant neoplasm. Distinguishing apocrine carcinoma from breast carcinoma metastasis is difficult even for pathologist. Most arise in regions of high apocrine gland density like axilla, and rarely on the scalp and eyelid, but it’s possible to occur elsewhere on the skin. Primary cutaneous apocrine carcinoma of the scalp is a rare malignancy most often reported in the literature as case reports or small case series. Giant form of primary cutaneous apocrine carcinoma in frontal region is not described in literature, to the best of our knowledge. There no established protocols for primary cutaneous apocrine carcinoma treatment.Case presentation: We report a case giant primary cutaneous apocrine carcinoma localized in frontal region. Definitive diagnosis of primary cutaneous apocrine carcinoma is made by biopsy with microscopic and immunohistochemical analysis. Wide surgical excision and reconstruction with large local transposition flap and split thickness skin grafts for secondary defect were our therapy of choice.Conclusion: Primary cutaneous apocrine carcinoma is very rare malignancy and giant form in not described yet. Surgical treatment provided the patients with the tumor free status as well satisfactory aesthetical appearances and quality of living.